Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Keane

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Pre-treatment neutrophil-lymphocyte ratio is associated with overall mortality in localized non-small cell lung cancer treated with stereotactic body radiotherapyNikhil Sebastian, Trudy Wu, Jose Bazan, et al.
Annals of Surgical Oncology|November 24, 2019
Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term OutcomesJon M Harrison, Jennifer Y Wo, Cristina R Ferrone, et al.
Nano Letters|July 1, 2011
Resistively detected nuclear magnetic resonance in n- and p-type GaAs quantum point contactsZ K Keane, M C Godfrey, J C H Chen, et al.
JTO Clinical and Research Reports|July 31, 2023
B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung AdenocarcinomaIbiayi Dagogo-Jack, Ivan Valiev, Nikita Kotlov, et al.
The Lancet. Oncology|March 26, 2011
A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysisTrupti Paranjape, Helen Heneghan, Robert Lindner, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 14, 2023
Portal Vein or Superior Mesenteric Vein Thrombosis with Dose-Escalated Radiation for Borderline or Locally Advanced Pancreatic CancerAlicia C Smart, Andrzej Niemierko, Jennifer Y Wo, et al.
Annals of Surgical Oncology|September 4, 2021
Neoadjuvant versus Postoperative Chemoradiotherapy is Associated with Improved Survival for Patients with Resectable Gastric and Gastroesophageal CancerDaniel W Kim, Grace Lee, Theodore S Hong, et al.
JTO Clinical and Research Reports|September 21, 2023
Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional StudyLeou Ismael Banla, Alice Tzeng, John P Baillieul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2021
Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal AdenocarcinomasJennifer Y Wo, Jeffrey W Clark, Christine E Eyler, et al.
Oncogene|December 6, 2011
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancerE S Ratner, F K Keane, R Lindner, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Pre-treatment neutrophil-lymphocyte ratio is associated with overall mortality in localized non-small cell lung cancer treated with stereotactic body radiotherapyNikhil Sebastian, Trudy Wu, Jose Bazan, et al.
Annals of Surgical Oncology|November 24, 2019
Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term OutcomesJon M Harrison, Jennifer Y Wo, Cristina R Ferrone, et al.
Nano Letters|July 1, 2011
Resistively detected nuclear magnetic resonance in n- and p-type GaAs quantum point contactsZ K Keane, M C Godfrey, J C H Chen, et al.
JTO Clinical and Research Reports|July 31, 2023
B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung AdenocarcinomaIbiayi Dagogo-Jack, Ivan Valiev, Nikita Kotlov, et al.
The Lancet. Oncology|March 26, 2011
A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysisTrupti Paranjape, Helen Heneghan, Robert Lindner, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 14, 2023
Portal Vein or Superior Mesenteric Vein Thrombosis with Dose-Escalated Radiation for Borderline or Locally Advanced Pancreatic CancerAlicia C Smart, Andrzej Niemierko, Jennifer Y Wo, et al.
Annals of Surgical Oncology|September 4, 2021
Neoadjuvant versus Postoperative Chemoradiotherapy is Associated with Improved Survival for Patients with Resectable Gastric and Gastroesophageal CancerDaniel W Kim, Grace Lee, Theodore S Hong, et al.
JTO Clinical and Research Reports|September 21, 2023
Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional StudyLeou Ismael Banla, Alice Tzeng, John P Baillieul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2021
Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal AdenocarcinomasJennifer Y Wo, Jeffrey W Clark, Christine E Eyler, et al.
Oncogene|December 6, 2011
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancerE S Ratner, F K Keane, R Lindner, et al.
Pageof 9